Clarification

Abstract

Articles| April 01 2008 Clarification Pediatr Rev (2008) 29 (4): 120. https://doi.org/10.1542/pir.29-4-120 Connected Content This is a correction to: Varicella-Zoster Virus Infections Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Twitter LinkedIn Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Clarification. Pediatr Rev April 2008; 29 (4): 120. https://doi.org/10.1542/pir.29-4-120 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search nav search search input Search input auto suggest search filter All PublicationsAll JournalsPediatrics In ReviewPediatricsHospital PediatricsNeoReviewsAAP Grand RoundsAAP NewsAll AAP Sites Search Advanced Search Topics: acyclovir, chickenpox, herpes zoster disease, tablet dosage form In the article on varicella-zoster infections in the January issue (Pediatr Rev. 2008;29:5–11), the oral dose of acyclovir for children is given as 20 mg/kg qid. To clarify, the dose is 20 mg/kg per dose qid. The dose recommended in the article for adolescents is 4,000 mg/day and is based on the treatment for adults who have zoster. The American Academy of Pediatrics Red Book (27th ed. 2006:785) cites a dose of 800 mg qid (3,200 mg/day) for adolescents, and the author of the article in the January issue recommends using that dose, although there should be no significant clinical difference between the two regimens. Acyclovir is available in 800-mg tablets. Patients at serious risk for or who have severe or potentially severe infections should be treated with intravenous acyclovir. View Original Article You do not currently have access to this content.